Ipilimumab Market – Industry Trends and Forecast to 2034.
A monoclonal antibody called Ipilimumab is utilized in cancer immunotherapy, specifically to treat melanoma. By identifying and triggering cytotoxic T-lymphocytes, it attacks cancer cells through a method of action.
